MannKind—developing pulmonary therapies and devices that help give people more control of their health

Changing lives for the better
Our founder, Alfred E. Mann, was a visionary in aerospace, medical technology, and biopharmaceuticals. But his true passion was helping others. It’s a simple notion with a profound impact. Since 1991, MannKind has been dedicated to developing therapies and devices that give people more control of their health—and the freedom to live life to its fullest.

Thinking beyond what’s possible
Our team of dedicated scientists and medical professionals are committed to developing inhaled therapeutic products to meet the needs of patients. How do we do it? By seeking open feedback and new ideas, encouraging expansive thinking, and challenging conventional wisdom at every turn.

Diversity in research
This big-picture approach starts in clinical trials. By including people from diverse backgrounds, we help ensure that our research reflects the global population. It not only makes our results more accurate, it underscores our broader commitment to inclusivity and equity in healthcare.

Transformative impact in pulmonary medicine
Leveraging our expertise in formulation and device engineering, we’ve helped alleviate the burden of diseases like diabetes and pulmonary arterial hypertension (PAH). And we’ve got more solutions on the way to meet the needs of people with nontuberculous mycobacterial (NTM) lung disease and pulmonary fibrotic diseases. Our ongoing research holds promise for improving pulmonary health outcomes and enhancing the quality of life for patients worldwide.

US-MED-0483 (03/2024) © Copyright 2024. All rights reserved. MannKind Corporation.